Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

Sacchi, S; Marcheselli, R; Bari, A; Buda, G; Molinari, A L; Baldini, L; Valisa, D; Cesaretti, M; Musto, P; Ronconi, S; Specchia, G; Silvestris, F; Guardigni, L; Ferrari, A; Chiappella, A; Carella, A M; Santoro, A; Di Raimondo, F; Marcheselli, L; Pozzi, S